title: Response to incremental doses of dobutamine early after reperfusion is predictive of the degree of myocardial salvage in dogs with experimental acute myocardial infarction.
abstract: OBJECTIVE
  We sought to determine whether the inotropic response to dobutamine might be useful for estimating the extent of viable myocardium soon after reperfusion.
  
  
  BACKGROUND
  Early identification of viable myocardium in the presence of severe left ventricular dysfunction after reperfusion is important for clinical decision making.
  
  
  METHODS
  Nine open-chest dogs had left anterior descending coronary artery occlusion for 40 to 180 min, followed by gradual reperfusion. The systolic thickening response to incremental dobutamine doses was measured with ultrasonic crystals and regional flow by microspheres.
  
  
  RESULTS
  Dogs were divided into two groups based on triphenyl tetralozium chloride infarct size (group 1: 9.3 +/- 3.0% risk area; group 2: 51.1 +/- 4.8%). In group 2 dogs with larger infarcts, regional flow during peak dobutamine was lower than it was in group 1 in endocardial (1.15 +/- 0.22 vs. 2.64 +/- 0.33 mL x min(-1) x g(-1)) and midwall (1.47 +/- 0.32 vs. 2.92 +/- 0.36 mL x min(-1) x g(-1)) layers, and endocardial flow in group 2 failed to increase from baseline (0.96 +/- 0.07 vs. 1.15 +/- 0.22 mL x min(-1) x g(-1)). Group 1 dogs demonstrated a dose dependent increase in systolic thickening with dobutamine versus a blunted response in group 2. The inotropic response to only 10 microg x kg(-1) x min(-1) of dobutamine was predictive of the degree of myocardial salvage.
  
  
  CONCLUSIONS
  In the early postischemic stunning phase of reperfusion, the inotropic response to dobutamine is predictive of the degree of myocardial salvage and ultimate infarct size. The ability to distinguish between stunned versus necrotic myocardium early after reperfusion was most likely due to the presence of subendocardial flow reserve during dobutamine in dogs with predominantly salvaged myocardium.
authors.affiliation: Department of Medicine, University of Virginia Health System, Charlottesville 22908, USA.
authors.forename: K
authors.initials: K
authors.lastname: Takehana
authors.forename: M
authors.initials: M
authors.lastname: Ruiz
authors.forename: F D
authors.initials: FD
authors.lastname: Petruzella
authors.forename: D D
authors.initials: DD
authors.lastname: Watson
authors.forename: G A
authors.initials: GA
authors.lastname: Beller
authors.forename: D K
authors.initials: DK
authors.lastname: Glover
mesh_terms: D000818:Animals; D002316:Cardiotonic Agents / Q000008:administration & dosage*; D004280:Dobutamine / Q000008:administration & dosage*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D006439:Hemodynamics; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D015425:Myocardial Reperfusion; D011237:Predictive Value of Tests; D012039:Regional Blood Flow; D013599:Systole; D013997:Time Factors
chemical_list: D002316:Cardiotonic Agents; D004280:Dobutamine